Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity

Richard T. Eastman(National Institutes of Health), Jayme L. Dahlin(Brigham and Women's Hospital)
bioRxiv (Cold Spring Harbor Laboratory)
October 24, 2023
Cited by 4


Related Papers